These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Rational design of a low molecular weight, stable, potent, and long-lasting GPR103 aza-β3-pseudopeptide agonist. Neveu C, Lefranc B, Tasseau O, Do-Rego JC, Bourmaud A, Chan P, Bauchat P, Le Marec O, Chuquet J, Guilhaudis L, Boutin JA, Ségalas-Milazzo I, Costentin J, Vaudry H, Baudy-Floc'h M, Vaudry D, Leprince J. J Med Chem; 2012 Sep 13; 55(17):7516-24. PubMed ID: 22800498 [Abstract] [Full Text] [Related]
23. Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity. Chartrel N, Dujardin C, Anouar Y, Leprince J, Decker A, Clerens S, Do-Régo JC, Vandesande F, Llorens-Cortes C, Costentin J, Beauvillain JC, Vaudry H. Proc Natl Acad Sci U S A; 2003 Dec 09; 100(25):15247-52. PubMed ID: 14657341 [Abstract] [Full Text] [Related]
24. Molecular cloning and functional characterization of the first non-mammalian 26RFa/QRFP orthologue in Goldfish, Carassius auratus. Liu Y, Zhang Y, Li S, Huang W, Liu X, Lu D, Meng Z, Lin H. Mol Cell Endocrinol; 2009 May 06; 303(1-2):82-90. PubMed ID: 19428995 [Abstract] [Full Text] [Related]
28. Identification of 26RFa from frog brain: a novel hypothalamic neuropeptide with orexigenic activity in mammals. Chartrel N, Bruzzone F, Dujardin C, Leprince J, Tollemer H, Anouar Y, Vallarino M, Costentin J, Vaudry H. Ann N Y Acad Sci; 2005 Apr 06; 1040():80-3. PubMed ID: 15891009 [Abstract] [Full Text] [Related]
34. The hypothalamic RFamide, QRFP, increases feeding and locomotor activity: The role of Gpr103 and orexin receptors. Cook C, Nunn N, Worth AA, Bechtold DA, Suter T, Gackeheimer S, Foltz L, Emmerson PJ, Statnick MA, Luckman SM. PLoS One; 2022 Apr 06; 17(10):e0275604. PubMed ID: 36251705 [Abstract] [Full Text] [Related]
35. Regulation of the expression of corticotropin-releasing factor gene by pyroglutamylated RFamide peptide in rat hypothalamic 4B cells. Ishigame N, Kageyama K, Takayasu S, Furumai K, Nakada Y, Daimon M. Endocr J; 2016 Oct 29; 63(10):919-927. PubMed ID: 27452579 [Abstract] [Full Text] [Related]
36. Characterization of peptide QRFP (26RFa) and its receptor from amphioxus, Branchiostoma floridae. Xu B, Bergqvist CA, Sundström G, Lundell I, Vaudry H, Leprince J, Larhammar D. Gen Comp Endocrinol; 2015 Jan 01; 210():107-13. PubMed ID: 25449662 [Abstract] [Full Text] [Related]
37. Anatomical distribution and biochemical characterization of the novel RFamide peptide 26RFa in the human hypothalamus and spinal cord. Bruzzone F, Lectez B, Tollemer H, Leprince J, Dujardin C, Rachidi W, Chatenet D, Baroncini M, Beauvillain JC, Vallarino M, Vaudry H, Chartrel N. J Neurochem; 2006 Oct 01; 99(2):616-27. PubMed ID: 16899066 [Abstract] [Full Text] [Related]
39. Blood Levels of Neuropeptide 26RFa in Relation to Anxiety and Aggressive Behavior in Humans-An Exploratory Study. Værøy H, Takhlidjt S, Cherifi Y, Lahaye E, Chartrel N, Fetissov SO. Brain Sci; 2023 Jan 31; 13(2):. PubMed ID: 36831780 [Abstract] [Full Text] [Related]
40. Structure-activity relationships of a series of analogues of the RFamide-related peptide 26RFa. Le Marec O, Neveu C, Lefranc B, Dubessy C, Boutin JA, Do-Régo JC, Costentin J, Tonon MC, Tena-Sempere M, Vaudry H, Leprince J. J Med Chem; 2011 Jul 14; 54(13):4806-14. PubMed ID: 21623631 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]